These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 744719)

  • 21. Combined vaccination of cattle against FMD and rabies.
    Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
    Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
    Beran J; Honegr K; Banzhoff A; Malerczyk C
    Vaccine; 2005 Jun; 23(30):3902-7. PubMed ID: 15917111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 24. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
    Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
    Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new, highly immunogenic duck embryo rabies vaccine.
    Glück R; Wegmann A; Germanier R; Keller H; Hess MW; Kraus-Ruppert R; Wandeler AI
    Lancet; 1984 Apr; 1(8381):844-5. PubMed ID: 6143152
    [No Abstract]   [Full Text] [Related]  

  • 27. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
    Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C
    Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies.
    Madhusudana SN; Anand NP; Shamsundar R
    Natl Med J India; 2001; 14(3):145-7. PubMed ID: 11467142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of purified chick embryo cell antirabies vaccine in healthy volunteers.
    Sehgal S; Bhardwaj M; Bhatia R
    J Commun Dis; 1988 Sep; 20(3):247-52. PubMed ID: 3256569
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.
    Kim MC; Kim MJ; Kwon YK; Lindberg AM; Joh SJ; Kwon HM; Lee YJ; Kwon JH
    Vaccine; 2009 Nov; 27(48):6688-94. PubMed ID: 19747575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man.
    Bijok U; Barth R; Gruschkau H; Vodopija I; Smerdel S; Kukla H; Geursen R
    J Commun Dis; 1984 Mar; 16(1):61-9. PubMed ID: 12055789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-exposure prophylaxis in Peace Corps volunteers with intradermal human diploid cell rabies vaccine.
    Rosa FW
    J Trop Med Hyg; 1983 Apr; 86(2):81-4. PubMed ID: 6887320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How far can the antigen content of tissue culture rabies vaccine be reduced safely?
    Beran J; Honegr K; Banzhoff A; Malerczyk C
    Vaccine; 2006 Mar; 24(13):2223-4. PubMed ID: 16406174
    [No Abstract]   [Full Text] [Related]  

  • 38. Availability of new rabies vaccine for human use.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jan; 47(1):12, 19. PubMed ID: 9450724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human diploid cell rabies vaccine.
    Med Lett Drugs Ther; 1980 Oct; 22(22):93-4. PubMed ID: 7442610
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.